Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Comment by sweenbyon Sep 23, 2010 10:33am
261 Views
Post# 17483302

RE: News

RE: News

2010-09-23 09:13 ET - News Release

Ms. Lynda Bloom reports

HALO EXTENDS COLD-LOST MINERALIZED TREND

Halo Resources Ltd.'s ground geophysical surveys have identified additional targets in the Cold-Lost mineralized corridor. Several Crone pulse electromagnetic (EM) (TDEM) anomalies have been interpreted that extend the prospective horizon over 1,000 metres to the east of the Lost deposit. In 2007, Halo discovered the Lost deposit, where recent drilling intersected massive sulphide intervals that assay up to 3.8 per cent copper and 12.6 per cent zinc over four metres, and 2 per cent copper and 6 per cent zinc over 11.8 metres, near surface.

The ground geophysical surveys confirm the extension of a continuous string of airborne VTEM anomalies that extend from Lost Lake, east to, and under Sherlett Lake (see figure below). The Lost deposit discovery was a result of drill testing airborne VTEM survey anomalies and generated the near-production opportunity being advanced by Halo's joint venture partner, Hudson Bay Mining and Smelting Co., Limited ("HudBay"), an affiliate of HudBay Minerals Inc. (TSX: HBM). The TDEM geophysical surveys provide greater depth penetration then the airborne surveys, with responses possible to 400 meters from surface. To-date no drilling has been done along the mineralized trend at depths greater than 200 meters and historical East Mine underground workings only extend to depths of approximately 100 meters.

<< Previous
Bullboard Posts
Next >>